853 Evofosfomide potentiates the efficacy of a novel anti-PD-L1/PD-L2 monoclonal antibody against immune excluded tumors by Michael Curran, James Barlow, Ahmad Salameh, Paul Blezinger, Christine Gagliardi, Matt Hemberger, Federica Pericle

829 A potent STING agonist in combination with a novel anti-PD-L1/PD-L2 antibody leads to significant tumor responses in checkpoint-refractory cancers by Michael Curran, James Barlow, Manuela Iezzi, Laura Conti, Elisabetta Bolli, Federica Cavallo, Ahmad Salameh, Paul Blezinger, Christine Gagliardi, Federica Pericle, Chiara Cossu